Published in Appl Immunohistochem Mol Morphol on May 01, 2010
Ancillary testing in lung cancer diagnosis. Pulm Med (2012) 0.92
Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis. Cell Cycle (2015) 0.79
TTF-1 Expression in Rectal Adenocarcinoma: A Case Report and Review of the Literature. Case Rep Oncol (2016) 0.75
Primary signet ring cell carcinoma of the lung with cerebellar metastasis showing full response to Cisplatin and docetaxel therapy. Case Rep Oncol Med (2014) 0.75
Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy. Prostate Cancer Prostatic Dis (2015) 0.75
Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res (2009) 1.96
Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol (2006) 1.80
Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology (2011) 1.67
Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem (2004) 1.53
Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer (2005) 1.52
Delay to formalin fixation effect on breast biomarkers. Mod Pathol (2009) 1.46
Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Ann Surg Oncol (2006) 1.39
Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol (2005) 1.35
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst (2010) 1.26
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. J Clin Oncol (2004) 1.23
Aberrant crypt foci. Anticancer Res (2006) 1.19
Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncol Rep (2008) 1.16
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol (2004) 1.13
Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg (2010) 1.12
Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res (2003) 1.10
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer (2005) 1.10
Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature. Int J Clin Exp Pathol (2008) 1.09
Malignant glomus tumor: a case report and review of literature, focusing on its clinicopathologic features and immunohistochemical profile. Am J Dermatopathol (2005) 1.08
Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol (2009) 1.08
Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms. BMC Clin Pathol (2005) 1.04
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer (2006) 1.03
Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control (2013) 1.03
Akt expression may predict favorable prognosis in cholangiocarcinoma. J Gastroenterol Hepatol (2006) 1.02
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax (2006) 1.02
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol (2011) 1.01
Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses. Head Neck (2004) 1.00
Isolated extramedullary relapse of acute lymphoblastic leukemia in the breast of an adolescent girl: radiologic findings and discussion. Pediatr Radiol (2010) 0.99
Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res (2009) 0.99
Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma. Ann Clin Lab Sci (2008) 0.99
Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. Hepatogastroenterology (2004) 0.96
Peripheral primitive neuroectodermal tumor of the mandible with cytogenetic and molecular biology aberrations. J Oral Maxillofac Surg (2005) 0.96
Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer. PLoS One (2012) 0.96
ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PLoS One (2013) 0.95
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. Int J Oncol (2005) 0.95
Pulmonary malignant granular cell tumor. World J Surg Oncol (2003) 0.94
Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J (2004) 0.93
Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines. BMC Cancer (2005) 0.93
Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res (2004) 0.92
TLE3 as a candidate biomarker of response to taxane therapy. Breast Cancer Res (2009) 0.92
Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res (2009) 0.92
Melanotic schwannoma with drop metastases to the caudal spine and high expression of CD117 (c-kit). J Neurooncol (2005) 0.92
Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer. Clin Lung Cancer (2009) 0.91
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. Am J Clin Pathol (2010) 0.91
Post-laparoscopic cholecystectomy pain: effects of intraperitoneal local anesthetics on pain control--a randomized prospective double-blinded placebo-controlled trial. Am Surg (2008) 0.90
Leukemoid reaction in pancreatic cancer: a case report and review of the literature. JOP (2006) 0.90
Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates. Ann Clin Lab Sci (2007) 0.90
Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol (2012) 0.90
Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia. Cancer J (2005) 0.90
Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma. Ann Clin Lab Sci (2010) 0.88
Aberrant crypt foci as precursors in colorectal cancer progression. J Surg Oncol (2008) 0.88
Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women. Int J Cancer (2013) 0.88
CD24 expression is an independent prognostic marker in cholangiocarcinoma. J Gastrointest Surg (2007) 0.87
The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer. PLoS One (2013) 0.87
Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. BMC Clin Pathol (2006) 0.87
Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer (2004) 0.86
Primary intraplacental gestational choriocarcinoma: histologic and genetic analyses. Int J Gynecol Pathol (2013) 0.86
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma. J Exp Clin Cancer Res (2008) 0.86
Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer. Mol Carcinog (2013) 0.85
Diagnostic and prognostic biomarkers in pancreatic carcinoma. Int J Clin Exp Pathol (2008) 0.85
Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol (2013) 0.85
Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: a meta-analysis. Int J Clin Exp Med (2009) 0.85
Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type. Histopathology (2012) 0.84
Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol (2003) 0.84
Photodynamic therapy for sarcoma pulmonary metastases: a preclinical toxicity study. Anticancer Res (2003) 0.84
Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma. PLoS One (2013) 0.84
The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma. PLoS One (2013) 0.82
Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Ann Clin Lab Sci (2008) 0.82
Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH. Mutat Res (2006) 0.82
Malignant hypercalcemia associated with a parathyroid macrocyst and the early genesis of a giant cell tumor. Am J Otolaryngol (2005) 0.82
Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. Int J Clin Exp Pathol (2011) 0.82
Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat (2013) 0.82
Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma. Int J Exp Pathol (2010) 0.82
Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions. Arch Pathol Lab Med (2011) 0.81
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma. Int J Gastrointest Cancer (2005) 0.81
Alpha-methylacyl-CoA racemase expression is upregulated in gastric adenocarcinoma: a study of 249 cases. Int J Clin Exp Pathol (2008) 0.80
Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies. BMC Gastroenterol (2014) 0.80
COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival. Ann Surg Oncol (2006) 0.80
Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma. Hepatogastroenterology (2007) 0.80
Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis. Diagn Mol Pathol (2004) 0.79
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer. Oncotarget (2013) 0.79
Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res (2009) 0.78
Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience. Am J Clin Oncol (2004) 0.77
Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma. Eur J Clin Invest (2011) 0.77
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence. BMC Cancer (2010) 0.77
Genetic and molecular abnormalities in cholangiocarcinogenesis. Anticancer Res (2009) 0.77
Cell cycle biology of fibrolamellar hepatocellular carcinoma. Int J Clin Exp Pathol (2010) 0.77